Over 13 years of web services experience helping organizations operate online and be found.

Get in touch

Life Sciences
Sirona Biochem
Sirona Biochem was founded in 2009 by its current Chairman and CEO, Dr. Howard Verrico. The Company’s first transaction was to acquire an exclusive global license to TFChem’s proprietary diabetes drug, the SGLT2 Inhibitor.